TDC
LAB icon

Thompson Davis & Co’s Standard BioTools LAB Stock Holding History

Thompson Davis & Co’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-250
Closed -$1K – 711
2018
Q1 		$1K Buy
+250
New +$1.64K ﹤0.01% 603
2014
Q4 		– Sell
-750
Closed -$18K – 1212
2014
Q3 		$18K Hold
750
– – 0.02% 501
2014
Q2 		$22K Buy
750
+125
+20% +$4K 0.03% 377
2014
Q1 		$28K Buy
625
+125
+25% +$5.5K 0.05% 338
2013
Q4 		$19K Buy
+500
New +$14.7K 0.03% 356

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return